image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

  2022 2021 2020 2019 2018

Year wise published articles

105 141 28 8 28

Year wise citations received

543 553 590 563 587
Journal total citations count 6601
Journal Impact Factor 6.49
Journal 5 years Impact Factor 12.17
Journal CiteScore 11.19
Journal h-index 41
Journal h-index since 2016 26
Bolu, Abdullah, Mehmet Sinan Aydin, Abdullah Akgün, Ali Co?kun, Beyazit Garip, Taner Öznur, Cemil Çelik, and Özcan Uzun. "Serum levels of high sensitivity c-reactive protein in drug-naïve first-episode psychosis and acute exacerbation of schizophrenia." Clinical Psychopharmacology and Neuroscience 17, no. 2 (2019): 244.
Quidé, Yann, Chiara C. Bortolasci, Briana Spolding, Srisaiyini Kidnapillai, Oliver J. Watkeys, Sarah Cohen-Woods, Vaughan J. Carr, Michael Berk, Ken Walder, and Melissa J. Green. "Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: moderation by childhood trauma severity." Progress in Neuro-Psychopharmacology and Biological Psychiatry 105 (2021): 110013.
Keinänen, Jaakko, Jaana Suvisaari, Jaakko Reinikainen, Tuula Kieseppä, Maija Lindgren, Teemu Mäntylä, Eva Rikandi, Jouko Sundvall, Minna Torniainen-Holm, and Outi Mantere. "Low-grade inflammation in first-episode psychosis is determined by increased waist circumference." Psychiatry research 270 (2018): 547-553.
Okusaga, Olaoluwa O. "6R-l-erythro-5, 6, 7, 8-tetrahydrobiopterin (BH4): A potential treatment for all symptom domains of schizophrenia." Medical hypotheses 82, no. 3 (2014): 395-397.
Liu, Yujie, Dan Zhang, Yuhang Cheng, and Zhili Li. "Elevated serum immunoinflammation-related protein complexes are associated with psychosis." Psychiatry research 230, no. 1 (2015): 96-101.
Pan, Shujuan, Yunlong Tan, Shangwu Yao, Xiaoyan Zhao, and Jing Xiong. "Serum high-sensitivity C-reactive protein: A delicate sentinel elevated in drug-free acutely agitated patients with schizophrenia." Psychiatry research 246 (2016): 89-94.
Mirzakhanian, Heline, Fiza Singh, and Kristin S. Cadenhead. "Biomarkers in psychosis: an approach to early identification and individualized treatment." Biomarkers in medicine 8, no. 1 (2014): 51-57.
Kao, Amy Chia-Ching, Philip WJ Burnet, and Belinda R. Lennox. "Can prebiotics assist in the management of cognition and weight gain in schizophrenia?." Psychoneuroendocrinology 95 (2018): 179-185.
Garcia-Alvarez, Leticia, Maria Paz Garcia-Portilla, Leticia Gonzalez-Blanco, Pilar Alejandra Saiz Martinez, Lorena de la Fuente-Tomas, Isabel Menendez-Miranda, Celso Iglesias, and Julio Bobes. "Biomarcadores sanguíneos diferenciales de las dimensiones psicopatológicas de la esquizofrenia." Revista de Psiquiatría y Salud Mental 9, no. 4 (2016): 219-227.
Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort studyImmunological mechanisms may play a role in symptomatology of patients with a psychotic disorder. Besides metabolic problems and medication use, inflammatory processes that may occur due to the disorder may cause increased inflammatory markers and concurrent psychiatric symptoms. The aim of this study is to investigate whether levels of C-reactive protein (CRP) and white blood cell count (WBC) are related to positive and negative symptoms of psychotic disorders, and whether age, gender, duration of illness, smoking behavior, haloperidol equivalents, mediation use, body mass, and metabolic syndrome affect this relation.
Ciocca, Giacomo, Judith Usall, Montse Dolz, Erika Limoncin, Giovanni L. Gravina, Eleonora Carosa, Bernardo Sanchez et al. "Sexual dysfunctions in people with first-episode psychosis assessed according to a gender perspective." Riv Psichiatr 50, no. 5 (2015): 239-244.
de Jager, José, Bahar Cirakoglu, Annet Nugter, and Jim van Os. "Intimacy and its barriers: A qualitative exploration of intimacy and related struggles among people diagnosed with psychosis." Psychosis 9, no. 4 (2017): 301-309.
Gawai, A. A., S. Das, and M. Nemade. "Synthesis, Preliminary Pharmacological and Acute Toxicity Studies of a New Series of 7-(2-(Benzo [d] thiazol-2-ylamino) ethoxy)-4-methyl-2H-chromen-2-one Derivatives with Atypical Antipsychotic Activity." Indian Journal of Pharmaceutical Sciences 81, no. 2 (2019): 241-248.
Hrdlicka, Michal, and Iva Dudova. "Atypical antipsychotics in the treatment of early-onset schizophrenia." Neuropsychiatric disease and treatment (2015).
Thanoon, Imad A., Mahfudh S. Hasan, and Faris A. Ahmed. "Lipid Peroxidation and Antioxidant Status in Schizophrenic Patients Treated by Quetiapine." Jordan Med. J 48, no. 1 (2014): 28-33.
McCann, Edward, Grainne Donohue, Jose de Jager, Annet Nugter, Jessica Stewart, and Jessica Eustace-Cook. "Sexuality and intimacy among people with serious mental illness: a qualitative systematic review." JBI Evidence Synthesis 17, no. 1 (2019): 74-125.
Kirino, Eiji. "Efficacy and safety of aripiprazole in child and adolescent patients." European child & adolescent psychiatry 21, no. 7 (2012): 361-368.
Hocaoglu, Cicek, Fatmagul H. Celik, Gokhan Kandemir, Hulya Guveli, and Bulent Bahceci. "Sexual dysfunction in outpatients with schizophrenia in Turkey: a cross-sectional study." Shanghai archives of psychiatry 26, no. 6 (2014): 347.
Huguelet, Philippe, Sylvia Mohr, Céline Miserez, Patrizia Castellano, Christian Lutz, Maria Boucherie, Michal Yaron, Nader Perroud, and Francesco Bianchi Demicheli. "An exploration of sexual desire and sexual activities of women with psychosis." Community mental health journal 51, no. 2 (2015): 229-238.
Shin, Wonsuk, Minji Bang, Anhye Kim, Doo-Yeoun Cho, and Sang-Hyuk Lee. "Influence of cytochrome P450 2D6 polymorphism on hippocampal white matter and treatment response in schizophrenia." npj Schizophrenia 7, no. 1 (2021): 1-7.